Contents
The NSPC Proove non-prosecution agreement recorded NSPC’s admission that physicians received kickbacks disguised as clinical research payments. In that criminal agreement, NSPC admitted that some physicians submitted inflated timesheets, including claims for work Proove employees had actually done. If you handled the research paperwork, physician payments or laboratory orders, the difference between the work recorded and the work performed is the heart of this case.
The Justice Department announced the agreement on August 6, 2021. The FBI and the Department of Health and Human Services Office of Inspector General investigated the matter. National Spine & Pain Center, known as NSPC, was a physician management services organization headquartered in Rockville, Maryland. Its affiliate Physical Medicine Associates, or PMA, joined it in the arrangement with Proove Biosciences, a genetics testing company formerly based in Irvine, California.
In its criminal non-prosecution agreement, NSPC admitted that some NSPC and PMA physicians described Proove’s research payments as “per test” or “per patient” payments. The company’s admission also connected those payments to expansion: certain NSPC personnel told Proove that its tests would not be offered at additional sites unless it was current on payments to the physicians. Proove, in turn, told NSPC that it expected the physicians to order a certain volume of tests.
The bargain ran in both directions. On the practice side, access to additional sites depended on keeping physician payments current. On the laboratory side, the expectation was test orders. We see a sales bargain dressed as research.
Proove’s tests purported to assess a patient’s risk of abusing certain prescription opioids and how patients metabolized certain drugs. Those were the patient-facing claims behind the product. The payment communications described in NSPC’s admission show the commercial bargain behind its use: a laboratory expecting orders and practice personnel expecting the laboratory to keep paying.
In the same criminal agreement, NSPC admitted that physicians completed timesheets overstating the time they spent on clinical research, and Proove used those timesheets to pay them. In some instances, the sheets credited physicians with tasks performed by Proove’s own employees. The result was physician payment for work the physician had not done.
That is a specific discrepancy an insider can explain. A timesheet identifies the person claiming the work. The person who actually performed the task can explain what happened. Read beside the payment record and the test orders, those accounts show how the research payment was generated and what business accompanied it.
The same question runs through referral payments disguised as ordinary business expenses: what service was the physician actually being paid to provide? Here, NSPC’s admission supplied an unusually direct answer. Some of the claimed services had been performed by employees of the company making the payment.
PMA received $1.1 million from Proove, while Medicare paid Proove approximately $4 million for claims arising from NSPC and PMA physician referrals. The Justice Department’s account places the money on both sides of the arrangement: payments from the laboratory to the practice, and government payments to the laboratory for the resulting referrals.
Clinical laboratory claims also have ordering and medical-necessity requirements, reflected in Medicare’s laboratory billing manual. That puts the patient’s order and clinical reason for testing alongside the research timesheet. For us, the useful account connects what the physician ordered, what the laboratory billed and what the physician or practice received for participating.
The referring practice and the laboratory submitting the claim occupied different parts of the payment chain. Someone handling physician compensation could see the money coming in, while someone handling laboratory billing could see the Medicare claims going out. Connecting those views explains how a research-payment arrangement reached public money.
NSPC and PMA had already agreed to a separate civil settlement of approximately $3.3 million, announced in April 2019. A former PMA physician assistant brought that qui tam case. The government alleged that nurse-practitioner and physician-assistant services were billed as physician services, and that urine-drug-test claims involved improper referrals and medically unnecessary testing.
The later criminal agreement supplied NSPC’s admissions about the Proove research-payment arrangement. The distinction matters to an insider who saw both: the practitioner identified on a bill, the reason for a urine test and the payment for a genetic-test referral describe different decisions inside a practice.
Kickbacks in health care are payments or other benefits knowingly exchanged to buy or reward referrals for business paid by federal health care programs. The Anti-Kickback Statute reaches both the person paying and the person receiving them. In the Proove arrangement, NSPC’s admission connected the research label to physician payments, expected test volume and false accounts of the work performed.
A different payment label appeared in Northwest Anesthesiology and Pain Services. The Justice Department alleged that physician bonuses followed laboratory referrals minus costs and fees, rather than the practice productivity described in the contracts. In both accounts, the payment’s name becomes less useful than the calculation and the business it rewards. A payroll or accounting employee may know that calculation better than anyone reading the finished claim.
The strongest account of a research-payment arrangement joins the stated work, the actual worker, the payment and the resulting test orders. We work through those connections with the person who saw them. A physician, practice administrator or laboratory employee may each know a different part of how the arrangement operated.
The 2020 Journal of Forensic and Investigative Accounting paper, A Forensic Accountant’s Guide to the Most Potent Federal Laws Used Against Healthcare Fraud, explains why inside knowledge matters to complex financial investigations. Its point fits a case where the timesheet named one worker and the task belonged to another.
The paper also explains how a civil False Claims Act case can address kickback allegations. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. If you want to report physician practice fraud, start with us and the part you know: who did the work, how the payment was approved or what orders the laboratory expected in return.
If the research timesheet, physician payment and laboratory order tell different stories, talk with our whistleblower experts about what you saw. We build the case with you and bring in physician-practice fraud whistleblower lawyers who understand laboratory referral arrangements. We stay beside you as the account moves from your knowledge of the work to the pursuit of a government recovery.